{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:31:11Z","timestamp":1790663471906,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,1,30]],"date-time":"2017-01-30T00:00:00Z","timestamp":1485734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2017,1,30]],"date-time":"2017-01-30T00:00:00Z","timestamp":1485734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Microbiol"],"DOI":"10.1038\/nmicrobiol.2016.272","type":"journal-article","created":{"date-parts":[[2017,1,30]],"date-time":"2017-01-30T10:08:53Z","timestamp":1485770933000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":98,"title":["Structural basis for antibody cross-neutralization of respiratory syncytial virus and human metapneumovirus"],"prefix":"10.1038","volume":"2","author":[{"given":"Xiaolin","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarrod J.","family":"Mousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5545-6871","authenticated-orcid":false,"given":"John T.","family":"Bates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"James E.","family":"Crowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore S.","family":"Jardetzky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,30]]},"reference":[{"key":"BFnmicrobiol2016272_CR1","volume-title":"Fields Virology","author":"PL Collins","year":"2013","unstructured":"Collins, P. L. & Karron, R. A. in Fields Virology 6th edn, Vol. 1 (eds Knipe, D. M. & Howley, P. M. ) Ch. 38 (Wolters Kluwer Health Adis (ESP), 2013)."},{"key":"BFnmicrobiol2016272_CR2","first-page":"39","volume":"372","author":"CB Hall","year":"2013","unstructured":"Hall, C. B., Simoes, E. A. & Anderson, L. J. Clinical and epidemiologic features of respiratory syncytial virus. Curr. Top. Microbiol. Immunol. 372, 39\u201357 (2013).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"BFnmicrobiol2016272_CR3","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1056\/NEJMoa043951","volume":"352","author":"AR Falsey","year":"2005","unstructured":"Falsey, A. R., Hennessey, P. A., Formica, M. A., Cox, C. & Walsh, E. E. Respiratory syncytial virus infection in elderly and high-risk adults. N. Engl. J. Med. 352, 1749\u20131759 (2005).","journal-title":"N. Engl. J. Med."},{"key":"BFnmicrobiol2016272_CR4","doi-asserted-by":"publisher","first-page":"92","DOI":"10.2174\/187152612800100099","volume":"12","author":"CB Hall","year":"2012","unstructured":"Hall, C. B. The burgeoning burden of respiratory syncytial virus among children. Infect. Disord. Drug Targets 12, 92\u201397 (2012).","journal-title":"Infect. Disord. Drug Targets"},{"key":"BFnmicrobiol2016272_CR5","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1056\/NEJMoa1204630","volume":"368","author":"KM Edwards","year":"2013","unstructured":"Edwards, K. M. et al. Burden of human metapneumovirus infection in young children. N. Engl. J. Med. 368, 633\u2013643 (2013).","journal-title":"N. Engl. J. Med."},{"key":"BFnmicrobiol2016272_CR6","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1056\/NEJMoa025472","volume":"350","author":"JV Williams","year":"2004","unstructured":"Williams, J. V. et al. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N. Engl. J. Med. 350, 443\u2013450 (2004).","journal-title":"N. Engl. J. Med."},{"key":"BFnmicrobiol2016272_CR7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2165\/00148581-200406030-00004","volume":"6","author":"C Fenton","year":"2004","unstructured":"Fenton, C., Scott, L. J. & Plosker, G. L. Palivizumab: a review of its use as prophylaxis for serious respiratory syncytial virus infection. Paediatr. Drugs 6, 177\u2013197 (2004).","journal-title":"Paediatr. Drugs"},{"key":"BFnmicrobiol2016272_CR8","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1542\/peds.102.3.531","volume":"102","author":"The IMpact-RSV Study Group","year":"1998","unstructured":"The IMpact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 102, 531\u2013537 (1998).","journal-title":"Pediatrics"},{"key":"BFnmicrobiol2016272_CR9","doi-asserted-by":"publisher","first-page":"13396","DOI":"10.1073\/pnas.1516698112","volume":"112","author":"S Bhattacharyya","year":"2015","unstructured":"Bhattacharyya, S., Gesteland, P. H., Korgenski, K., Bjornstad, O. N. & Adler, F. R. Cross-immunity between strains explains the dynamical pattern of paramyxoviruses. Proc. Natl Acad. Sci. USA 112, 13396\u201313400 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnmicrobiol2016272_CR10","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/nature12442","volume":"501","author":"D Corti","year":"2013","unstructured":"Corti, D. et al. Cross-neutralization of four paramyxoviruses by a human monoclonal antibody. Nature 501, 439\u2013443 (2013).","journal-title":"Nature"},{"key":"BFnmicrobiol2016272_CR11","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1093\/infdis\/jiu307","volume":"211","author":"JE Schuster","year":"2015","unstructured":"Schuster, J. E. et al. A broadly neutralizing human monoclonal antibody exhibits in vivo efficacy against both human metapneumovirus and respiratory syncytial virus. J. Infect. Dis. 211, 216\u2013225 (2015).","journal-title":"J. Infect. Dis."},{"key":"BFnmicrobiol2016272_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.coviro.2014.01.005","volume":"5","author":"TS Jardetzky","year":"2014","unstructured":"Jardetzky, T. S. & Lamb, R. A. Activation of paramyxovirus membrane fusion and virus entry. Curr. Opin. Virol. 5, 24\u201333 (2014).","journal-title":"Curr. Opin. Virol."},{"key":"BFnmicrobiol2016272_CR13","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nsmb.2250","volume":"19","author":"X Wen","year":"2012","unstructured":"Wen, X. et al. Structure of the human metapneumovirus fusion protein with neutralizing antibody identifies a pneumovirus antigenic site. Nat. Struct. Mol. Biol. 19, 461\u2013463 (2012).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"BFnmicrobiol2016272_CR14","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1126\/science.1234914","volume":"340","author":"JS McLellan","year":"2013","unstructured":"McLellan, J. S. et al. Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody. Science 340, 1113\u20131117 (2013).","journal-title":"Science"},{"key":"BFnmicrobiol2016272_CR15","doi-asserted-by":"publisher","first-page":"7788","DOI":"10.1128\/JVI.00555-11","volume":"85","author":"JS McLellan","year":"2011","unstructured":"McLellan, J. S., Yang, Y., Graham, B. S. & Kwong, P. D. Structure of the respiratory syncytial virus fusion glycoprotein in the post-fusion conformation reveals preservation of neutralizing epitopes. J. Virol. 85, 7788\u20137796 (2011).","journal-title":"J. Virol."},{"key":"BFnmicrobiol2016272_CR16","doi-asserted-by":"publisher","first-page":"9619","DOI":"10.1073\/pnas.1106536108","volume":"108","author":"KA Swanson","year":"2011","unstructured":"Swanson, K. A. et al. Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers. Proc. Natl Acad. Sci. USA 108, 9619\u20139624 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnmicrobiol2016272_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nature04322","volume":"439","author":"HS Yin","year":"2006","unstructured":"Yin, H. S., Wen, X., Paterson, R. G., Lamb, R. A. & Jardetzky, T. S. Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation. Nature 439, 38\u201344 (2006).","journal-title":"Nature"},{"key":"BFnmicrobiol2016272_CR18","doi-asserted-by":"publisher","first-page":"e1005859","DOI":"10.1371\/journal.ppat.1005859","volume":"12","author":"V Mas","year":"2016","unstructured":"Mas, V. et al. Engineering, structure and immunogenicity of the human metapneumovirus F protein in the postfusion conformation. PLoS Pathogens 12, e1005859 (2016).","journal-title":"PLoS Pathogens"},{"key":"BFnmicrobiol2016272_CR19","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/nsmb.3267","volume":"23","author":"MG Joyce","year":"2016","unstructured":"Joyce, M. G. et al. Iterative structure-based improvement of a fusion-glycoprotein vaccine against RSV. Nat. Struct. Mol. Biol. 23, 811\u2013820 (2016).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"BFnmicrobiol2016272_CR20","doi-asserted-by":"publisher","first-page":"e0159709","DOI":"10.1371\/journal.pone.0159709","volume":"11","author":"JC Boyington","year":"2016","unstructured":"Boyington, J. C. et al. Structure-based design of head-only fusion glycoprotein immunogens for respiratory syncytial virus. PLoS ONE 11, e0159709 (2016).","journal-title":"PLoS ONE"},{"key":"BFnmicrobiol2016272_CR21","doi-asserted-by":"publisher","first-page":"e0128779","DOI":"10.1371\/journal.pone.0128779","volume":"10","author":"GB Stewart-Jones","year":"2015","unstructured":"Stewart-Jones, G. B. et al. A cysteine zipper stabilizes a pre-fusion F glycoprotein vaccine for respiratory syncytial virus. PLoS ONE 10, e0128779 (2015).","journal-title":"PLoS ONE"},{"key":"BFnmicrobiol2016272_CR22","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1126\/science.1243283","volume":"342","author":"JS McLellan","year":"2013","unstructured":"McLellan, J. S. et al. Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus. Science 342, 592\u2013598 (2013).","journal-title":"Science"},{"key":"BFnmicrobiol2016272_CR23","doi-asserted-by":"publisher","first-page":"e0155917","DOI":"10.1371\/journal.pone.0155917","volume":"11","author":"X Wen","year":"2016","unstructured":"Wen, X. et al. A chimeric pneumovirus fusion protein carrying neutralizing epitopes of both MPV and RSV. PLoS ONE 11, e0155917 (2016).","journal-title":"PLoS ONE"},{"key":"BFnmicrobiol2016272_CR24","doi-asserted-by":"publisher","first-page":"e1005035","DOI":"10.1371\/journal.ppat.1005035","volume":"11","author":"MS Gilman","year":"2015","unstructured":"Gilman, M. S. et al. Characterization of a prefusion-specific antibody that recognizes a quaternary, cleavage-dependent epitope on the RSV fusion glycoprotein. PLoS Pathog. 11, e1005035 (2015).","journal-title":"PLoS Pathog."},{"key":"BFnmicrobiol2016272_CR25","first-page":"323","volume":"386","author":"PS Lee","year":"2015","unstructured":"Lee, P. S. & Wilson, I. A. Structural characterization of viral epitopes recognized by broadly cross-reactive antibodies. Curr. Top. Microbiol. Immunol. 386, 323\u2013341 (2015).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"BFnmicrobiol2016272_CR26","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.coviro.2015.04.002","volume":"11","author":"NA Doria-Rose","year":"2015","unstructured":"Doria-Rose, N. A. & Joyce, M. G. Strategies to guide the antibody affinity maturation process. Curr. Opin. Virol. 11, 137\u2013147 (2015).","journal-title":"Curr. Opin. Virol."},{"key":"BFnmicrobiol2016272_CR27","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.cell.2015.04.028","volume":"161","author":"AG Schmidt","year":"2015","unstructured":"Schmidt, A. G. et al. Viral receptor-binding site antibodies with diverse germline origins. Cell 161, 1026\u20131034 (2015).","journal-title":"Cell"},{"key":"BFnmicrobiol2016272_CR28","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/j.cell.2015.05.007","volume":"161","author":"T Zhou","year":"2015","unstructured":"Zhou, T. et al. Structural repertoire of HIV-1-neutralizing antibodies targeting the CD4 supersite in 14 donors. Cell 161, 1280\u20131292 (2015).","journal-title":"Cell"},{"key":"BFnmicrobiol2016272_CR29","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1107\/S0907444903028956","volume":"60","author":"LC Storoni","year":"2004","unstructured":"Storoni, L. C., McCoy, A. J. & Read, R. J. Likelihood-enhanced fast rotation functions. Acta Crystallogr. D 60, 432\u2013438 (2004).","journal-title":"Acta Crystallogr. D"},{"key":"BFnmicrobiol2016272_CR30","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1107\/S0907444994003112","volume":"50","author":"Collaborative Computational Project, Number 4","year":"1994","unstructured":"Collaborative Computational Project, Number 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D 50, 760\u2013763 (1994).","journal-title":"Acta Crystallogr. D"},{"key":"BFnmicrobiol2016272_CR31","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/978-1-60327-058-8_28","volume":"426","author":"PH Zwart","year":"2008","unstructured":"Zwart, P. H. et al. Automated structure solution with the PHENIX suite. Methods Mol. Biol. 426, 419\u2013435 (2008).","journal-title":"Methods Mol. Biol."},{"key":"BFnmicrobiol2016272_CR32","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1107\/S0907444902016657","volume":"58","author":"PD Adams","year":"2002","unstructured":"Adams, P. D. et al. PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr. D 58, 1948\u20131954 (2002).","journal-title":"Acta Crystallogr. D"},{"key":"BFnmicrobiol2016272_CR33","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. COOT: model-building tools for molecular graphics. Acta Crystallogr. D 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. D"},{"key":"BFnmicrobiol2016272_CR34","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1128\/JVI.06335-11","volume":"86","author":"SA Smith","year":"2012","unstructured":"Smith, S. A. et al. Persistence of circulating memory B cell clones with potential for dengue virus disease enhancement for decades following infection. J. Virol. 86, 2665\u20132675 (2012).","journal-title":"J. Virol."}],"container-title":["Nature Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nmicrobiol2016272.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nmicrobiol2016272","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nmicrobiol2016272.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T21:35:34Z","timestamp":1671744934000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nmicrobiol2016272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,30]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,4]]}},"alternative-id":["BFnmicrobiol2016272"],"URL":"https:\/\/doi.org\/10.1038\/nmicrobiol.2016.272","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727259896.793530224","asserted-by":"object"}]},"ISSN":["2058-5276"],"issn-type":[{"value":"2058-5276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,30]]},"assertion":[{"value":"22 August 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"One of the authors (J.E.C.) declares a competing interest. J.E.C. is a consultant to Compuvax and a member of the Scientific Advisory Board of Meissa Vaccines. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16272"}}